Related Experiment Video

Updated: Aug 27, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

510

[Imipenem-cilastatin-relebactam used to treat ventilator-associated pneumonia developing after infection with

Ondřej Zahornacký1, Štefan Porubčin, Alena Rovňáková

  • 1Clinic of Infectology and Travel Medicine, Faculty of Medicine, University of Pavel Josef Šafařík, Košice, Slovak Repubic,

Klinicka Mikrobiologie a Infekcni Lekarstvi
|October 2, 2022
PubMed

Insights

This study details using imipenem-relebactam to treat ventilator-associated pneumonia in a pregnant patient post-SARS-CoV-2 infection. This last-resort antibiotic combination offers a potential treatment option for severe respiratory infections.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Critical Care Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a severe complication, particularly in patients with SARS-CoV-2 infection.
  • Carbapenem resistance necessitates novel therapeutic strategies.
  • Imipenem-relebactam represents a combination therapy for challenging bacterial infections.

Purpose of the Study:

  • To describe the successful use of imipenem-relebactam in treating VAP.
  • To highlight a treatment option for a pregnant patient with a complex infection.
  • To provide insights into the management of multidrug-resistant infections in critical care.

Main Methods:

  • Case report detailing clinical presentation and management.
  • Administration of imipenem-relebactam for VAP.
  • Monitoring of patient response and outcomes.

Main Results:

  • Successful treatment of ventilator-associated pneumonia.
  • Positive clinical outcome in a young pregnant patient.
  • Demonstrated efficacy of imipenem-relebactam in a challenging case.

Conclusions:

  • Imipenem-relebactam is a viable option for treating VAP, even in complex patient populations.
  • This combination therapy can be effective against resistant pathogens.
  • Further research is warranted to explore its broader application.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.0K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.4K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
429
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
320
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
194
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
287
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
185